MONTREAL, QUEBEC -- (MARKET WIRE) -- May 08, 2007 -- Ambrilia Biopharma Inc. (TSX: AMB), a biopharmaceutical company developing novel small molecules and peptides to treat infectious diseases and cancer, announced today that it will be hosting a conference call and webcast on Thursday, May 10th, at 9:00 AM ET, to discuss the first quarter 2007 financial results and provide an update on its development program.
